Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. 2013

Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.

OBJECTIVE Lack of gadolinium-contrast wash-in on first-pass perfusion imaging, early gadolinium-enhanced imaging, or late gadolinium-enhanced (LGE) cardiovascular magnetic resonance (CMR) imaging after revascularized ST-elevation myocardial infarction (STEMI) is commonly referred to as microvascular obstruction (MVO). Additionally, T2-weighted imaging allows for the visualization of infarct-related oedema and intramyocardial haemorrhage (IMH) within the infarction. However, the exact histopathological correlate of the contrast-devoid core and its relation to IMH is unknown. RESULTS In eight Yorkshire swine, the circumflex coronary artery was occluded for 75 min by a balloon catheter. After 7 days, CMR with cine imaging, T2-weighted turbospinecho, and LGE was performed. Cardiovascular magnetic resonance images were compared with histological findings after phosphotungstic acid-haematoxylin and anti-CD31/haematoxylin staining. These findings were compared with CMR findings in 27 consecutive PCI-treated STEMI patients, using the same scanning protocol. In the porcine model, the infarct core contained extensive necrosis and erythrocyte extravasation, without intact vasculature and hence, no MVO. The surrounding-gadolinium-enhanced-area contained granulation tissue, leucocyte infiltration, and necrosis with morphological intact microvessels containing microthrombi, without erythrocyte extravasation. Areas with IMH (median size 1.92 [0.36-5.25] cm(3)) and MVO (median size 2.19 [0.40-4.58] cm(3)) showed close anatomic correlation [intraclass correlation coefficient (ICC) 0.85, r = 0.85, P = 0.03]. Of the 27 STEMI patients, 15 had IMH (median size 6.60 [2.49-9.79] cm(3)) and 16 had MVO (median size 4.31 [1.05-7.57] cm(3)). Again, IMH and MVO showed close anatomic correlation (ICC 0.87, r = 0.93, P < 0.001). CONCLUSIONS The contrast-devoid core of revascularized STEMI contains extensive erythrocyte extravasation with microvascular damage. Attenuating the reperfusion-induced haemorrhage may be a novel target in future adjunctive STEMI treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008536 Meglumine 1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. Methylglucamine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009204 Myocardial Revascularization The restoration of blood supply to the myocardium. (From Dorland, 28th ed) Internal Mammary Artery Implantation,Myocardial Revascularizations,Revascularization, Myocardial,Revascularizations, Myocardial
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D003328 Coronary Thrombosis Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION. Thrombosis, Coronary,Coronary Thromboses,Thromboses, Coronary

Related Publications

Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
November 2010, European radiology,
Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
March 2005, European heart journal,
Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
December 2014, European radiology,
Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
March 1998, Circulation,
Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
August 2020, The Canadian journal of cardiology,
Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
November 2010, Circulation journal : official journal of the Japanese Circulation Society,
Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
September 2009, Clinical research in cardiology : official journal of the German Cardiac Society,
Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
February 2010, Circulation,
Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
July 2012, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance,
Lourens F H J Robbers, and Elise S Eerenberg, and Paul F A Teunissen, and Matthijs F Jansen, and Maurits R Hollander, and Anton J G Horrevoets, and Paul Knaapen, and Robin Nijveldt, and Martijn W Heymans, and Marcel M Levi, and Albert C van Rossum, and Hans W M Niessen, and C Bogdan Marcu, and Aernout M Beek, and Niels van Royen
January 2014, Cardiology in review,
Copied contents to your clipboard!